172 related articles for article (PubMed ID: 19448977)
1. The functional antagonist Met-RANTES: a modified agonist that induces differential CCR5 trafficking.
Kiss DL; Longden J; Fechner GA; Avery VM
Cell Mol Biol Lett; 2009; 14(4):537-47. PubMed ID: 19448977
[TBL] [Abstract][Full Text] [Related]
2. Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.
Longden J; Cooke EL; Hill SJ
Br J Pharmacol; 2008 Apr; 153(7):1513-27. PubMed ID: 18223665
[TBL] [Abstract][Full Text] [Related]
3. CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network.
Escola JM; Kuenzi G; Gaertner H; Foti M; Hartley O
J Biol Chem; 2010 Dec; 285(53):41772-80. PubMed ID: 21041313
[TBL] [Abstract][Full Text] [Related]
4. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
[TBL] [Abstract][Full Text] [Related]
5. Endocytosis and recycling of the HIV coreceptor CCR5.
Signoret N; Pelchen-Matthews A; Mack M; Proudfoot AE; Marsh M
J Cell Biol; 2000 Dec; 151(6):1281-94. PubMed ID: 11121442
[TBL] [Abstract][Full Text] [Related]
6. Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5.
Bönsch C; Munteanu M; Rossitto-Borlat I; Fürstenberg A; Hartley O
PLoS One; 2015; 10(4):e0125396. PubMed ID: 25923671
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
Chvatchko Y; Proudfoot AE; Buser R; Juillard P; Alouani S; Kosco-Vilbois M; Coyle AJ; Nibbs RJ; Graham G; Offord RE; Wells TN
J Immunol; 2003 Nov; 171(10):5498-506. PubMed ID: 14607956
[TBL] [Abstract][Full Text] [Related]
8. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
9. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
[TBL] [Abstract][Full Text] [Related]
10. Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions.
Nakata H; Kruhlak M; Kamata W; Ogata-Aoki H; Li J; Maeda K; Ghosh AK; Mitsuya H
Antivir Ther; 2010; 15(3):321-31. PubMed ID: 20516552
[TBL] [Abstract][Full Text] [Related]
11. Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.
Sabbe R; Picchio GR; Pastore C; Chaloin O; Hartley O; Offord R; Mosier DE
J Virol; 2001 Jan; 75(2):661-71. PubMed ID: 11134280
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent.
Signoret N; Hewlett L; Wavre S; Pelchen-Matthews A; Oppermann M; Marsh M
Mol Biol Cell; 2005 Feb; 16(2):902-17. PubMed ID: 15591129
[TBL] [Abstract][Full Text] [Related]
13. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
15. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor.
Chen C; Li J; Bot G; Szabo I; Rogers TJ; Liu-Chen LY
Eur J Pharmacol; 2004 Jan; 483(2-3):175-86. PubMed ID: 14729105
[TBL] [Abstract][Full Text] [Related]
16. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
[TBL] [Abstract][Full Text] [Related]
17. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
Proudfoot AE; Buser R; Borlat F; Alouani S; Soler D; Offord RE; Schröder JM; Power CA; Wells TN
J Biol Chem; 1999 Nov; 274(45):32478-85. PubMed ID: 10542293
[TBL] [Abstract][Full Text] [Related]
18. G protein subtype-specific signaling bias in a series of CCR5 chemokine analogs.
Lorenzen E; Ceraudo E; Berchiche YA; Rico CA; Fürstenberg A; Sakmar TP; Huber T
Sci Signal; 2018 Oct; 11(552):. PubMed ID: 30327411
[TBL] [Abstract][Full Text] [Related]
19. pH-independent endocytic cycling of the chemokine receptor CCR5.
Signoret N; Christophe T; Oppermann M; Marsh M
Traffic; 2004 Jul; 5(7):529-43. PubMed ID: 15180829
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization.
Zhao J; Ma L; Wu YL; Wang P; Hu W; Pei G
J Cell Biochem; 1998 Oct; 71(1):36-45. PubMed ID: 9736452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
